Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,065 | -13,510 | -1,021 | -20,500 | -27,890 |
| Depreciation Amortization | 3,939 | 2,599 | 1,409 | 845 | 380 |
| Accounts receivable | N/A | -1,608 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 824 | 342 | N/A | N/A |
| Other Working Capital | 2,030 | -997 | -82 | 1,342 | 2,870 |
| Other Operating Activity | -16,436 | -16,710 | -18,618 | -79 | 670 |
| Operating Cash Flow | $-37,532 | $-29,402 | $-17,970 | $-18,392 | $-23,970 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -714 | -566 | -461 | -357 | -780 |
| Net Acquisitions | 6,489 | 6,489 | 6,489 | 0 | 0 |
| Other Investing Activity | -200 | -163 | -214 | 0 | 0 |
| Investing Cash Flow | $5,575 | $5,760 | $5,814 | $-357 | $-780 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 21,810 | 6,844 | N/A | N/A |
| Debt Repayment | N/A | -9,927 | -9,107 | N/A | N/A |
| Other Financing Activity | 29,760 | 18,822 | 20,520 | 11,842 | 18,000 |
| Financing Cash Flow | $29,760 | $30,705 | $18,257 | $11,842 | $18,000 |
| Exchange Rate Effect | 421 | -27 | 5 | 0 | 0 |
| Beginning Cash Position | 7,160 | 7,160 | 7,160 | 14,067 | 20,820 |
| End Cash Position | 5,384 | 14,196 | 13,266 | 7,160 | 14,060 |
| Net Cash Flow | $-1,776 | $7,036 | $6,106 | $-6,907 | $-6,750 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,532 | -29,402 | -17,970 | -18,392 | -23,970 |
| Capital Expenditure | N/A | -566 | -461 | N/A | N/A |
| Free Cash Flow | -37,532 | -29,968 | -18,431 | -18,392 | -23,970 |